
BlueDot Narrated The Danger of ‘Invisible’ Biolabs Across the U.S.
Dec 5, 2025
08:10
Audio versions of blogs and papers from BlueDot courses.
As synthetic biology techniques develop and the barriers to entry become lower, we are increasingly seeing the development of privately-operated biological labs. These often enforce less stringent safety standards than those in academia, and can fall through the cracks of regulatory oversight. This article focuses on a recent example in California, emphasising the need for a unified regulatory system and increased federal oversight for these labs, especially those working with dangerous pathogens.
Original text:
https://time.com/6309643/invisible-biolabs/
Author(s):
Dan Greene and Jassi Pannu and Allison Berke
A podcast by BlueDot Impact.
